Displaying 1 - 12 of 18
Immune-Mediated and Cholestatic Diseases

GSK: "Investigating IBAT inhibition in itch – a new tool for an age-old problem?" (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

GSK: "Practical tips towards providing holistic care to patients with PBC" (Complete Session)

Webcasts
View
Viral Hepatitis

GSK: “Looking to the future of hepatitis B: how can we achieve functional cure?” (Complete Session)

Webcasts
View
Viral Hepatitis

GSK: "Looking To The Future Of Hepatitis B: An Expert Review Of Quantitative Hepatitis B Surface Antigen Assessment” (Complete...

Webcasts
View
Viral Hepatitis

Introduction

Webcasts
View
Immune-Mediated and Cholestatic Diseases

What is the unmet burden of itch from an HCP perspective?

Webcasts
View
Immune-Mediated and Cholestatic Diseases

How can we face itch in the present?

Webcasts
View
Viral Hepatitis

Benefits and barriers to achieving functional cure

Webcasts
View
Viral Hepatitis

The importance of quantitative hepatitis B surface antigen in achieving functional cure: A clinical perspective

Webcasts
View
Immune-Mediated and Cholestatic Diseases

What is the unmet burden of itch from a patient perspective?

Webcasts
View
Immune-Mediated and Cholestatic Diseases

IBAT inhibition: a tool for the future?

Webcasts
View
Immune-Mediated and Cholestatic Diseases

What are the unmet needs in PBC according to a patient advocate?

Webcasts
View
Displaying 1 - 12 of 18